13D Filing: Culpepper Peter R and Provectus Biopharmaceuticals Inc. (NYSEMKT:PVCT)

Name of
Reporting Persons

Peter R. Culpepper

Check the Appropriate Box if a Member
of a Group*

(a)  ☒

(b)  ☐

SEC Use Only

Source of Funds*

PF

Check Box if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)    ☐

Citizenship or Place of
Organization

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

Sole Voting Power

3,474,998

Shared Voting Power

0

Sole Dispositive Power

3,474,998

Shared Dispositive Power

0

Aggregate Amount Beneficially Owned by Each Reporting Person

3,474,998

Check Box if the Aggregate Amount in
Row (11) Excludes Certain Shares*    ☐

Percent of Class Represented by Amount
in Row (11)

1.4%

Type of Reporting Person*

IN